As of 2024-12-13, the Relative Valuation of Biodesix, Inc. (BDSX) is (5.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Biodesix, Inc. based on Relative Valuation is -502.2%.
The range of the Relative Valuation is (4.08) - (5.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 21.5x | 17.4x |
| Forward P/E multiples | 12.9x - 18.7x | 17.0x |
| Fair Price | (4.08) - (5.64) | (5.19) |
| Upside | -416.2% - -537.1% | -502.2% |
| Date | P/E |
| 2024-12-11 | -4.30 |
| 2024-12-10 | -4.38 |
| 2024-12-09 | -4.51 |
| 2024-12-06 | -4.48 |
| 2024-12-05 | -4.35 |
| 2024-12-04 | -4.48 |
| 2024-12-03 | -4.51 |
| 2024-12-02 | -4.51 |
| 2024-11-29 | -4.78 |
| 2024-11-27 | -4.73 |
| 2024-11-26 | -4.76 |
| 2024-11-25 | -4.42 |
| 2024-11-22 | -4.25 |
| 2024-11-21 | -3.98 |
| 2024-11-20 | -3.95 |
| 2024-11-19 | -4.12 |
| 2024-11-18 | -4.18 |
| 2024-11-15 | -4.47 |
| 2024-11-14 | -4.65 |
| 2024-11-13 | -4.65 |
| 2024-11-12 | -4.65 |
| 2024-11-11 | -4.68 |
| 2024-11-08 | -4.55 |
| 2024-11-07 | -4.42 |
| 2024-11-06 | -4.42 |
| 2024-11-05 | -4.45 |
| 2024-11-04 | -4.61 |
| 2024-11-01 | -4.32 |
| 2024-10-31 | -5.64 |
| 2024-10-30 | -5.51 |
| 2024-10-29 | -5.48 |
| 2024-10-28 | -5.31 |
| 2024-10-25 | -5.44 |
| 2024-10-24 | -5.41 |
| 2024-10-23 | -5.25 |
| 2024-10-22 | -5.34 |
| 2024-10-21 | -5.31 |
| 2024-10-18 | -5.34 |
| 2024-10-17 | -5.41 |
| 2024-10-16 | -5.51 |
| 2024-10-15 | -5.38 |
| 2024-10-14 | -5.31 |
| 2024-10-11 | -5.61 |
| 2024-10-10 | -5.64 |
| 2024-10-09 | -5.44 |
| 2024-10-08 | -5.58 |
| 2024-10-07 | -5.61 |
| 2024-10-04 | -5.61 |
| 2024-10-03 | -5.61 |
| 2024-10-02 | -5.81 |